News
The prevalence of ideal CV health metrics varies across populations, but even modest improvement may help mitigate the ...
6h
Bizcommunity on MSNLiving well with autoimmune disorders: Insights from MedshieldYour immune system is supposed to protect you from viruses, bacteria, and other harmful invaders. However, when you have an ...
Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...
A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results